In this study, we evaluated the frequency of ABCB1 polymorphisms in lung cancer patients and studied whether the ABCB1 polymorphisms were associated with clinical outcomes or toxicity of taxane‐based chemotherapy. The gene discussed is ABCB1; the disease is lung carcinoma.